185. Safety Study by Validated Immunoassays in a Phase III Study of Subjects with Inherited Retinal Dystrophy Due to Mutations in the Gene Encoding Human Retinal Pigment Epithelium-Specific Protein 65 (RPE65) Injected with Adeno-Associated Viral Vectors

Abstract

Open access

Peer reviewed

Daniel J Hui, Yifeng Chen, Thomas Antrilli, Yun Liu, Romuald Corbau, Stephen R Russell, Albert M Maguire, Jean Bennett and Katherine A High

Molecular therapy, Vol.24, pp.S72-S73

05/2016

DOI: 10.1016/S1525-0016(16)32994-X

Files and links (1)

url

https://doi.org/10.1016/S1525-0016(16)32994-XView

Published (Version of record) Open Access

Title: Subtitle: 185. Safety Study by Validated Immunoassays in a Phase III Study of Subjects with Inherited Retinal Dystrophy Due to Mutations in the Gene Encoding Human Retinal Pigment Epithelium-Specific Protein 65 (RPE65) Injected with Adeno-Associated Viral Vectors
Creators: Daniel J Hui - Spark Therapeutics (United States)
Yifeng Chen - Spark Therapeutics (United States)
Thomas Antrilli - Spark Therapeutics (United States)
Yun Liu - Spark Therapeutics (United States)
Romuald Corbau - Spark Therapeutics (United States)
Stephen R Russell - University of Iowa
Albert M Maguire - University of Pennsylvania
Jean Bennett - University of Pennsylvania
Katherine A High - Spark Therapeutics (United States)
Resource Type: Abstract
Publication Details: Molecular therapy, Vol.24, pp.S72-S73
DOI: 10.1016/S1525-0016(16)32994-X
ISSN: 1525-0016
eISSN: 1525-0024
Publisher: Elsevier Inc
Language: English
Date published: 05/2016
Academic Unit: Ophthalmology and Visual Sciences
Record Identifier: 9984186985502771

24 Record Views